Investigational Product 2

**Investigational Product 2** is a non-specific intervention label used in the registered Phase 1 study NCT07682948 sponsored by Korea United Pharm. The public study record evaluates pharmacokinetic drug-drug interaction, safety, and tolerability of two unnamed investigational products, identified in the title as UIC202601 and UIC202602, but does not publicly disclose which underlying code or active ingredient corresponds to Investigational Product 2. It was administered alone and in combination with Investigational Product 1 in healthy volunteers in a study associated with hypertension and dyslipidemia. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07682948))

Other names

Investigational Product 2试验产品2